Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Long acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD005613.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 18 octubre 2006see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Trastornos metabólicos y endocrinos

Copyright:
  1. Copyright © 2007 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Karl Horvath

    Correspondencia a: Department of Internal Medicine, Medical University Graz, Garz, Austria

    [email protected]

  • Klaus Jeitler

    Department of Internal Medicine, Medical University Graz, Garz, Austria

  • Andrea Berghold

    Institute for Medical Informatics, Statisitics and Documentation, Leopold Auenbrugger Medical University Graz, Graz, Austria

  • Johannes Plank

    Department of Internal Medicine, Leopold Auenbrugger Medical University Graz, Graz, Austria

  • Thomas R Pieber

    Department of Internal Medicine, Leopold Auenbrugger Medical University Graz, Graz, Austria

  • Andrea Siebenhofer

    University of Medicine, Leopold Auenbrugger Medical University of Graz, Graz, Austria

Contributions of authors

Karl Horvath: protocol development, quality assessment of trials, data extraction, development of final review, corresponding author

Klaus Jeitler: protocol development, searching for trials, quality assessment of trials, data extraction

Andrea Berghold: protocol development, statistical analysis, development of final review

Johannes Plank: development of final review

Thomas Pieber: protocol design

Andrea Siebenhofer: Protocol development, quality assessment of trials, data extraction, development of final review

Sources of support

Internal sources

  • Department of Internal Medicine, University Hospital Graz; Institute for Medical Informatics, Statistics and Documentation, University of Graz, Austria.

External sources

  • No sources of support supplied

Declarations of interest

The research group performed several studies in short and long acting insulin analogues with the companies Sanofi‐Aventis, Eli Lilly, Novo Nordisk. TR Pieber was or is currently a paid consultant for these companies.

Version history

Published

Title

Stage

Authors

Version

2020 Nov 09

(Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus

Review

Thomas Semlitsch, Jennifer Engler, Andrea Siebenhofer, Klaus Jeitler, Andrea Berghold, Karl Horvath

https://doi.org/10.1002/14651858.CD005613.pub4

2007 Apr 18

Long‐acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

Review

Karl Horvath, Klaus Jeitler, Andrea Berghold, Susanne H Ebrahim, Thomas W Gratzer, Johannes Plank, Thomas Kaiser, Thomas R Pieber, Andrea Siebenhofer

https://doi.org/10.1002/14651858.CD005613.pub3

2006 Oct 18

Long acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

Protocol

Karl Horvath, Klaus Jeitler, Andrea Berghold, Johannes Plank, Thomas R Pieber, Andrea Siebenhofer

https://doi.org/10.1002/14651858.CD005613.pub2

2006 Jan 25

Long acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

Protocol

Karl Horvath, Klaus Jeitler, Andrea Berghold, Johannes Plank, Thomas R Pieber, Andrea Siebenhofer

https://doi.org/10.1002/14651858.CD005613

Keywords

MeSH

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.